Enhancement of the in vivo antitumor activity of clofarabine by 1-β-d-[4-thio-arabinofuranosyl]-cytosine

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 2, 2009, Pages 253-261

  Parker, William B ^a   Shaddix, Sue C ^a   Gilbert, Karen S ^a   Shepherd, Rodney V ^a   Waud, William R ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

1 d 4 Thio arabinofuranosyl cytosine; Anti solid tumor activity; Arabinofuranosyl cytosine; Clofarabine; Synergistic antitumor activity

Indexed keywords

1 BETA DEXTRO (4 THIO ARABINOFURANOSYL)CYTOSINE; CLOFARABINE; CYTARABINE; CYTOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DOSE REDUCTION; DRUG METABOLISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA; LYMPHATIC LEUKEMIA; LYMPHOMA; MONOTHERAPY; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADENINE NUCLEOTIDES; ANIMALS; ANTINEOPLASTIC AGENTS; ARABINONUCLEOSIDES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MICE; MICE, NUDE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67349186631     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0862-z     Document Type: Article

References (29)

1. PL Bonate L Arthaud WR Cantrell Jr K Stephenson JA Secrist III S Weitman 2006 Discovery and development of clofarabine: a nucleoside analogue for treating cancer Nat Rev Drug Discov 5 855 863 (Pubitemid 44480539)
2. S Faderl V Gandhi MJ Keating S Jeha W Plunkett HM Kantarjian 2005 The role of clofarabine in hematologic and solid malignancies-development of a next-generation nucleoside analog Cancer 103 1985 1995 (Pubitemid 40605104)
3. HM Kantarjian S Jeha V Gandhi M Wess S Faderl 2007 Clofarabine: past, present, and future Leuk Lymphoma 48 1922 1930 (Pubitemid 47542978)
4. T Cooper M Ayres B Nowak V Gandhi 2005 Biochemical modulation of cytarabine triphosphate by clofarabine Cancer Chemother Pharmacol 55 361 368 (Pubitemid 40379260)
5. S Faderl V Gandhi S O'Brien P Bonate J Cortes E Estey M Beran W Wierda G Garcia-Manero A Ferrajoli Z Estrov FJ Giles M Du M Kwari M Keating W Plunkett H Kantarjian 2005 Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias Blood 105 940 947 (Pubitemid 40170859)
6. S Faderl S Verstovsek J Cortes F Ravandi M Beran G Garcia-Manero A Ferrajoli Z Estrov S O'Brien C Koller FJ Giles W Wierda M Kwari HM Kantarjian 2006 Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older Blood 108 45 51 (Pubitemid 43990611)
7. P Gidwani KH Ramesh Y Liu EA Kolb 2008 The combination of clofarabine and cytarabine in pediatric relapsed acute lymphoblastic leukemia: a case report Chemotherapy 54 120 124
8. KN Tiwari AT Shortnacy-Fowler L Cappellacci WB Parker WR Waud JA Montgomery JA Secrist III 2000 Synthesis of 4?-thio-β-d-arabinofuranosyl- cytosine (4?-thio-ara-C) and comparison of its anticancer activity with that of ara-C Nucleosides Nucleotides Nucleic Acids 19 329 340 (Pubitemid 30230045)
9. WR Waud KS Gilbert RV Shepherd JA Montgomery JA Secrit III 2003 Preclinical antitumor activity of 4?-thio-beta-d-arabinofuranosylcytosine (4?-thio-ara-C) Cancer Chemother Pharmacol 51 422 426 (Pubitemid 36649140)
10. WR Waud RV Shepherd KS Gilbert KN Tiwari JA Secrist III 2004 Precinical antitumor activity of 4?-thio-β-d-arabinofuranosylcytosine (4?-thio-ara-C, OSI-7836) in human leukemia and lymphoma xenograft models Proc Am Assoc Cancer Res 45 714
11. WB Parker SC Shaddix LM Rose WR Waud DS Shewach KN Tiwari JA Secrist III 2000 Metabolism of 4?-thio-β-d-arabinofuranosylcytosine in CEM cells Biochem Pharmacol 60 1925 1932
12. F Richardson C Black K Richardson A Franks E Wells S Karimi G Sennello K Hart D Meyer D Emerson E Brown J LeRay C Nilsson B Tomkinson R Bendele 2005 Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors Cancer Chemother Pharmacol 55 213 221 (Pubitemid 40142885)
13. ML Clarke VL Damaraju J Zhang D Mowles T Tackaberry T Lang KM Smith JD Young B Tomkinson CE Cass 2006 The role of human nucleoside transporters in cellular uptake of 4?-thio-beta-d-arabinofuranosylcytosine and beta-d-arabinosylcytosine Mol Pharmacol 70 303 310 (Pubitemid 43920820)
14. KA Richardson TP Vega FC Richardson CL Moore JC Rohloff B Tomkinson RA Bendele RD Kuchta 2004 Polymerization of the triphosphates of AraC, 2?,2?-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase Biochem Pharmacol 68 2337 2346 (Pubitemid 39535106)
15. H Someya SC Shaddix KN Tiwari JA Secrist III WB Parker 2003 Phosphorylation of 4?-thio-β-d-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase J Pharmacol Exp Ther 304 1314 1322 (Pubitemid 36254447)
16. H Someya WR Waud WB Parker 2006 Long intracellular retention of 4?-thio-arabinofuranosylcytosine 5?-triphosphate as a critical factor for the anti-solid tumor activity of 4?-thio-arabinofuranosylcytosine Cancer Chemother Pharmacol 57 772 780
17. JV Thottassery L Westbrook H Someya WB Parker 2006 c-Abl-independent p73 stabilization during gemcitabine- or 4?-thio-beta-d-arabinofuranosylcytosine- induced apoptosis in wild-type and p53-null colorectal cancer cells Mol Cancer Ther 5 400 410
18. G Goss LL Siu I Gauthier EX Chen AM Oza R Goel J Maroun J Powers W Walsh M Maclean DW Drolet J Rusk LK Seymour Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group 2006 A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group Cancer Chemother Pharmacol 58 703 710 (Pubitemid 44167397)
19. CP Lee MJ de Jonge AE O'Donnell KL Schothorst J Hanwell JB Chick RA Brooimans LM Adams DW Drolet JS de Bono SB Kaye IR Judson J Verweij 2006 A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies Clin Cancer Res 12 2841 2848 (Pubitemid 43752125)
20. DJ Dykes BJ Abbott JG Mayo SD Harrison Jr WR Laster L Simpson-Herren DP Griswold Jr 1992 Development of human tumor xenograft models for in vivo evaluation of new antitumor drugs Contrib Oncol Basel Karger 42 1 22
21. V Gandhi H Kantarjian S Faderl P Bonate M Du M Ayres MB Rios MJ Keating W Plunkett 2003 Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias Clin Cancer Res 9 6335 6342 (Pubitemid 38031817)
22. WR Waud SM Schmid JA Montgomery JA Secrist III 2000 Preclinical antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl) adenine (Cl-F-ara-A) Nucleosides Nucleotides Nucleic Acids 19 447 460 (Pubitemid 30230053)
23. WB Parker SC Shaddix CH Chang EL White LM Rose RW Brockman AT Shortnancy JA Montgomery JA Secrist III LL Bennett Jr 1991 Effects of 2-chloro-9-(2-deoxy- 2-fluoro-β-d-arabinofuranosyl) adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5-triphosphate Cancer Res 51 2386 2394
24. C Xie W Plunkett 1995 Metabolism and actions of 2-chloro-9-(2-deoxy-2- fluoro-beta-d-arabinofuranosyl)-adenine in human lymphoblastoid cells Cancer Res 55 2847 2852
25. WB Parker SC Shaddix LM Rose DS Shewach LW Hertel JA Secrist III JA Montgomery LL Bennett Jr 1999 Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2-fluoro-β-d-arabinofuranosyl) adenine, 2-chloro-9-(2-deoxy-2-fluoro-β-d-ribofuranosyl) adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro-β-d-ribofuranosyl) adenine in CEM cells Mol Pharmacol 55 515 520 (Pubitemid 29128108)
26. T Spasokoukotskaja M Sasvári-Székely G Keszler F Albertioni S Eriksson M Staub 1999 Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity Eur J Cancer 35 1862 1867 (Pubitemid 29512320)
27. Z Csapó M Sasvári-Székely T Spasokoukotskaja I Talianidis S Eriksson M Staub 2001 Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes Biochem Pharmacol 61 191 197 (Pubitemid 32121783)
28. G Keszler T Spasokoukotskaja M Sasvári-Székely S Eriksson M Staub 2006 Deoxycytidine kinase is reversibly phosphorylated in normal human lymphocytes Nucleosides Nucleotides Nucleic Acids 25 1147 1151 (Pubitemid 44651863)
29. M Qian X Wang K Shanmuganathan CK Chu JM Gallo 1994 Pharmacokinetics of the anticancer agent 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl) adenine in rats Cancer Chemother Pharmacol 33 484 488 (Pubitemid 24082342)